.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2015 for a tremend...
.On the heels of a stage 3 succeed that stopped working to make an impression on clients, Ironwood P...
.Don't stop Monte Rosa Therapies right now. The Boston-based biotech is actually having a ball after...
.Accept to recently's Chutes & Ladders, our summary of significant leadership hirings, firings an...
.Commemorating his business's upsized going public (IPO), Septerna chief executive officer Jeffrey F...
.AbbVie has gone back to the source of its antipsychotic goliath Vraylar trying to find another hit,...
.GenSight Biologics is full weeks away from lacking cash. Again. The biotech only has enough money t...
.Monopar Rehabs is recovering a drug from the scrap heap of AstraZeneca's uncommon disease pipeline....
.Along with new information out on Arcus Biosciences' experimental HIF-2a prevention, one team of pr...
.After developing a genetics treatment alliance along with Dyno Therapeutics in 2020, Roche is back ...